Skip to main content
Premium Trial:

Request an Annual Quote

AnaSpec, In Vitro Ink Distribution Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AnaSpec has reached a non-exclusive distribution deal with In Vitro covering a broad spectrum of AnaSpec products in Europe, the two companies and Eurogentec Group, AnaSpec's parent company, announced on Wednesday.

Financial and other terms of the deal were not disclosed.

Under the agreement In Vitro will distribute AnaSpec's catalog and custom products for peptides, fluorescent dyes, antibodies, assay kits, and amino acids throughout Europe. In Vitro has offices in Sweden, Estonia, Denmark, and Norway.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.